Asthma and lower airway diseaseAssociations between outdoor fungal spores and childhood and adolescent asthma hospitalizations
Section snippets
Study design and population
The Melbourne Air Pollen Children and Adolescent Health (MAPCAH) study is a case-crossover study of 644 children and adolescents (aged 2-17 years) with “incident” asthma admitted to the Royal Children's Hospital in Melbourne, Australia, between September 2009 and December 2011. This study used a bidirectional time-stratified case-crossover design that has been shown to be well suited for studying the effects of transient short-term exposures (fungi spore release, air pollution changes) on the
MAPCAH participants' characteristics
The participants recruited (n = 644) were predominantly boys (63.2%); the median age of all participants was 5.2 years (range, 2-17 years), with 90% younger than 10 years. Most (69.6%) participants had HRV infection detected at admission. Skin prick tests for fungal sensitization were obtained for 630 participants, and it was found that 8.9% were sensitized to Alternaria only, 6.5% to Cladosporium only, and 13.7% to Alternaria and Cladosporium (Table I).
Fungal spore distribution
The most prevalent fungi taxa detected
Discussion
Using a case-crossover approach, we found that exposures to spores of several outdoor fungal taxa, including some that, individually, have not been reported in previous research, were associated with the risk of asthma exacerbations in children and adolescents. Alternaria, Leptosphaeria, Coprinus, and Drechslera spores were associated with asthma hospitalizations on the day of exposure. In addition, there were associations with Alternaria, Coprinus, Drechslera, and Stemphylium 1 day after
References (44)
- et al.
Differential effects of outdoor versus indoor fungal spores on asthma morbidity in inner-city children
J Allergy Clin Immunol
(2010) An update on pollen and fungal spore aerobiology
J Allergy Clin Immunol
(2002)- et al.
An Australian national panel study of diurnal temperature range and children's respiratory health
Ann Allergy Asthma Immunol
(2014) - et al.
Mold and Alternaria skin test reactivity and asthma in children in Connecticut
Ann Allergy Asthma Immunol
(2011) - et al.
Fungi and allergic lower respiratory tract diseases
J Allergy Clin Immunol
(2012) - et al.
The role of fungal spores in thunderstorm asthma
Chest
(2003) - et al.
Influence of outdoor aeroallergens on hospitalization for asthma in Canada
J Allergy Clin Immunol
(2004) - et al.
Relationship of outdoor air quality to pediatric asthma exacerbations
Ann Allergy Asthma Immunol
(2003) - et al.
Global burden of asthma among children
Int J Tubercul Lung Dis
(2014) Australian Centre for Asthma Monitoring in Australia 2011: with a focus chapter on chronic obstructive pulmonary disease. Asthma Series No. 4
(2011)
Asthma hospitalisations in Australia 2010-11. Cat. No. ACM 27
The burden of asthma in the United States
Am J Respir Crit Care Med
Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children
Thorax
Association between human rhinovirus C and severity of acute asthma in children
Eur Respir J
A case-crossover design to examine the role of aeroallergens and respiratory viruses on childhood asthma exacerbations requiring hospitalization: the MAPCAH study
Biometr Biostat
Association between domestic mould and mould components, and asthma and allergy in children: a systematic review
Eur Respir J
Long-term exposure to air pollution and the incidence of asthma: meta-analysis of cohort studies
Air Qual Atmosph Health
The link between fungi and severe asthma: a summary of the evidence
Eur Respir J
Outdoor fungi and child asthma health service attendances
Pediatr Allergy Immunol
Asthma exacerbations in children associated with rhinovirus but not human metapneumovirus infection
J Infect Dis
Severe asthma with fungal sensitization
Curr Allergy Asthma Rep
Case-crossover design in air pollution epidemiology
Eur Respir J
Cited by (0)
The Melbourne Air Pollen Children and Adolescent Health study was funded by the National Health and Medical Research Council (NHMRC) Project ID: 541934, but the NHMRC had no part in the study design, collection, analysis, or interpretation of the data, the writing of this manuscript, or the decision to submit it for publication. R.T. is funded by an NHMRC PhD Postgraduate Scholarship and a Centre for Air quality & health Research and evaluation (NHMRC Centre of Research Excellence) top-up scholarship. S.C.D. and A.J.L. are funded by the NHMRC.
Disclosure of potential conflict of interest: R. Tham has received grants from the National Health and Medical Research Council (NHMRC) and the Center for Air quality & health Research and evaluation. S. C. Dharmage, A. J. Lowe, P. Bardin, M. L. K. Tang, M. J. Abramson, and B. Erbas have received grants from the NHMRC. E. Newbigin has received grants from the NHMRC and the Allergy Immunology Foundation of Australasia, has consultant arrangements with Ryco filters, and has received money from Stallergenes to support the Melbourne pollen count. M. J. Abramson holds investigator-initiated grants from Pfizer and Boehringer-Ingelheim for unrelated research, has undertaken an unrelated consultancy for AstraZeneca, and has received assistance with conference attendance from Boehringer-Ingelheim and Sanofi. The rest of the authors declare that they have no relevant conflicts of interest.